DE4219526C2 - Pharmazeutisches Mittel - Google Patents

Pharmazeutisches Mittel

Info

Publication number
DE4219526C2
DE4219526C2 DE4219526A DE4219526A DE4219526C2 DE 4219526 C2 DE4219526 C2 DE 4219526C2 DE 4219526 A DE4219526 A DE 4219526A DE 4219526 A DE4219526 A DE 4219526A DE 4219526 C2 DE4219526 C2 DE 4219526C2
Authority
DE
Germany
Prior art keywords
composition according
component
cyclosporin
components
triglycerides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE4219526A
Other languages
German (de)
English (en)
Other versions
DE4219526A1 (de
Inventor
Armin Meinzer
Birgit Hauer
Ulrich Posanski
Jacky Vonderscher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE4219526(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Priority to DE4244930A priority Critical patent/DE4244930C2/de
Publication of DE4219526A1 publication Critical patent/DE4219526A1/de
Application granted granted Critical
Publication of DE4219526C2 publication Critical patent/DE4219526C2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/06—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with glycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
DE4219526A 1991-06-27 1992-06-15 Pharmazeutisches Mittel Expired - Lifetime DE4219526C2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE4244930A DE4244930C2 (de) 1991-06-27 1992-06-15 Verwendung eines nachbehandelten Umesterungsproduktes von Maisöl mit Glycerin in pharmazeutischen Mitteln

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919113872A GB9113872D0 (en) 1991-06-27 1991-06-27 Improvements in or relating to organic compounds

Publications (2)

Publication Number Publication Date
DE4219526A1 DE4219526A1 (de) 1993-03-18
DE4219526C2 true DE4219526C2 (de) 1999-04-22

Family

ID=10697415

Family Applications (3)

Application Number Title Priority Date Filing Date
DE4219526A Expired - Lifetime DE4219526C2 (de) 1991-06-27 1992-06-15 Pharmazeutisches Mittel
DE4244930A Expired - Lifetime DE4244930C2 (de) 1991-06-27 1992-06-15 Verwendung eines nachbehandelten Umesterungsproduktes von Maisöl mit Glycerin in pharmazeutischen Mitteln
DE4244986A Expired - Lifetime DE4244986B4 (de) 1991-06-27 1992-06-15 Umesterungsprodukt von Maisöl und Glycerin

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE4244930A Expired - Lifetime DE4244930C2 (de) 1991-06-27 1992-06-15 Verwendung eines nachbehandelten Umesterungsproduktes von Maisöl mit Glycerin in pharmazeutischen Mitteln
DE4244986A Expired - Lifetime DE4244986B4 (de) 1991-06-27 1992-06-15 Umesterungsprodukt von Maisöl und Glycerin

Country Status (38)

Country Link
EP (2) EP0953630B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JP2653958B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (3) KR0131064B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1077798C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT403436B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU659460B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (2) CA2175842C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (2) CH684163A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1906A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ281790B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (3) DE4219526C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (2) DK0953630T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EE (1) EE03108B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (2) ES2142818T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (2) FI109454B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (2) FR2678169B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB9113872D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3032366T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (2) HK57196A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU216792B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE73662B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (3) IL102310A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1254401B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU88138A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9203236A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY109512A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (2) NO303964B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ243309A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH30337A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (2) PT953630E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (2) RO111021B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2143919C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SA (1) SA92130213B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK278759B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW267943B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA35559C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UY (1) UY23864A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA924719B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
PT1033128E (pt) 1993-09-28 2008-08-08 Scherer Gmbh R P Fabrico de cápsulas de gelatina mole
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
US5891846A (en) * 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
WO1995022343A1 (fr) * 1994-02-17 1995-08-24 Shiseido Company, Ltd. Composition d'emulsion a base de cyclosporine
NZ270145A (en) * 1994-03-01 1996-08-27 Lilly Co Eli Non-aqueous pharmaceutical formulation for oral administration comprising water-insoluble active agent, fatty acid solubilising agent, an oil and a surface active agent
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
ES2133655T3 (es) * 1994-03-31 1999-09-16 Unilever Nv Aceites con bajo contenido de acidos grasos saturados.
PE52896A1 (es) * 1994-10-26 1996-12-12 Novartis Ag Composicion farmaceutica
GB2308545B (en) * 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
BR9509550A (pt) 1994-11-03 1997-09-16 Dresden Arzneimittel Formulações de ciclosporina para administração oral com composição simples e alta biodisponibilidade e processo para sua produção
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
WO1996036330A2 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
EP0827402A2 (en) * 1995-05-17 1998-03-11 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US6696413B2 (en) * 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19544507B4 (de) * 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CN1104258C (zh) * 1996-05-29 2003-04-02 周德和 用于环孢霉素a的赋形剂
BR9706804A (pt) * 1996-06-19 1999-11-03 Novartis Ag Preparações de cápsula macia contendo ciclosporina.
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
US6517860B1 (en) 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
WO1999027946A1 (en) * 1997-12-02 1999-06-10 Chong Kun Dang Corp. Pharmaceutical composition comprising cyclosporin solid-state microemulsion
JP4718653B2 (ja) * 1997-03-12 2011-07-06 アボツト・ラボラトリーズ シクロスポリンの投与のための親水性二成分系
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
US6258783B1 (en) 1997-04-29 2001-07-10 Bernard Charles Sherman Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
SI0999838T1 (en) * 1997-07-29 2002-08-31 Pharmacia & Upjohn Company Self-emulsifying formulation for lipophilic compounds
EP0999826B1 (en) * 1997-07-29 2004-05-06 PHARMACIA & UPJOHN COMPANY Self-emulsifying formulation for lipophilic compounds
NZ502566A (en) 1997-07-29 2002-03-28 Upjohn Co Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation containing a pyranone and a basic amine
US20030220234A1 (en) 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
JP2001520170A (ja) 1997-10-16 2001-10-30 ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム Ｎｆ−ａｔ３機能に関連した心肥大動物モデルと治療法
DE69842121D1 (de) 1997-12-10 2011-03-17 Cyclosporine Therapeutics Ltd Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
PT982035E (pt) * 1998-08-18 2004-08-31 Panacea Biotec Ltd Composicao de ciclosporina compreendendo um veiculo hidrofilo
MXPA01005884A (es) * 1998-12-11 2002-04-24 Pharmasolutions Inc Composiciones auto-emulsionantes para medicamentos escasamente solubles en agua.
JP2002534370A (ja) 1998-12-30 2002-10-15 デクセル リミテッド サイクロスポリンを送達するための分散可能な濃縮物
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
CN1167462C (zh) * 1999-03-09 2004-09-22 杭州华东医药集团生物工程研究所有限公司 一种含环孢素的药物组合物
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
WO2001032143A1 (en) * 1999-11-02 2001-05-10 Cipla Ltd. A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and a process for preparation thereof
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
GB0019118D0 (en) * 2000-08-03 2000-09-27 Danisco Solid phase glycerolysis
BR0113108A (pt) * 2000-08-08 2003-06-10 Kao Corp Composição de óleo/gordura
US7115565B2 (en) 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
NZ531946A (en) 2001-10-19 2005-09-30 Isotechnika Inc Preconcentrate formulations comprising cyclosporin analogue microemulsions that reduce adverse effects while maintaining high bioavailability
CA2461740C (en) 2001-10-19 2013-02-12 Isotechnika Inc. Synthesis of cyclosporin analogs
KR100441167B1 (ko) * 2001-12-27 2004-07-21 씨제이 주식회사 마이크로에멀젼 예비 농축액 조성물
KR100525234B1 (ko) * 2003-02-19 2005-10-28 한국유나이티드제약 주식회사 사이클로스포린 함유 연질캅셀제 및 그 제조방법
GT200500310A (es) 2004-11-19 2006-06-19 Compuestos organicos
GB0504950D0 (en) 2005-03-10 2005-04-20 Novartis Ag Organic compositions
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
MD3347G2 (ro) * 2006-12-26 2008-01-31 Институт Сельскохозяйственной Техники "Mecagro" Procedeu de obţinere a esterilor metilici din ulei de rapiţă
ITPD20070049A1 (it) * 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
US8911777B2 (en) 2007-04-04 2014-12-16 Sigmoid Pharma Limited Pharmaceutical composition of tacrolimus
CN101199836B (zh) * 2007-11-07 2011-03-30 安徽省药物研究所 一种阶段释放型环孢素a固体微乳制剂及其微乳固化方法
GB2483815B (en) 2009-05-18 2013-12-25 Sigmoid Pharma Ltd Composition comprising oil drops
IN2012DN00781A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2009-08-12 2015-06-26 Sigmoid Pharma Ltd
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) * 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
FR2971941B1 (fr) 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
HUE053624T2 (hu) 2014-11-07 2021-07-28 Sublimity Therapeutics Ltd Ciklosporint tartalmazó készítmények
JPWO2020050182A1 (ja) * 2018-09-06 2020-09-10 株式会社カマタ カプセル充填用液状組成物及びカプセル剤
HUE061877T2 (hu) * 2018-11-26 2023-08-28 Hepion Pharmaceuticals Inc Ciklosporin-analógok gyógyszerkészítményei

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
DE3915617A1 (de) * 1988-05-13 1989-11-16 Sandoz Ag Kompositionen zur topischen anwendung enthaltend cyclosporine
DE3924207A1 (de) * 1988-07-21 1990-01-25 Biogal Gyogyszergyar Cyclosporin(e) enthaltende, intravenoes verabreichbare arzneimittelpraeparate und verfahren zu ihrer herstellung sowie ihre verwendung
DE3930928A1 (de) * 1988-09-16 1990-03-22 Sandoz Ag Cyclosporin enthaltende pharmazeutische formulierungen
DE4003844A1 (de) * 1989-02-09 1990-08-16 Sandoz Ag Neue cyclosporin enthaltende galenische formulierungen
DE4005190A1 (de) * 1989-02-20 1990-08-23 Sandoz Ag Neue cyclosporinhaltige galenische formen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) * 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
FR2344283A1 (fr) * 1976-03-17 1977-10-14 Gattefosse Ets Sa Nouveau melange de glycerides utile comme nutriment lipidique
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
AU558155B2 (en) * 1982-02-01 1987-01-22 Sandoz Ltd. Treating multiple sclerosis with dihydro-cyclosporin d
DE3444893A1 (de) * 1984-12-08 1986-06-12 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von fettsaeuremethylestern
JPS62201591A (ja) * 1986-02-28 1987-09-05 Shoichi Shimizu 油脂のグリセロリシス法
JP2632010B2 (ja) * 1988-01-29 1997-07-16 三共株式会社 シクロスポリン製剤
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins
JPH0738771B2 (ja) * 1989-01-17 1995-05-01 花王株式会社 液状食用油組成物
AU6785490A (en) * 1989-12-18 1991-06-20 Kraft General Foods, Inc. Low-saturate edible oils and transesterification methods for production thereof
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
DE3915617A1 (de) * 1988-05-13 1989-11-16 Sandoz Ag Kompositionen zur topischen anwendung enthaltend cyclosporine
DE3924207A1 (de) * 1988-07-21 1990-01-25 Biogal Gyogyszergyar Cyclosporin(e) enthaltende, intravenoes verabreichbare arzneimittelpraeparate und verfahren zu ihrer herstellung sowie ihre verwendung
DE3930928A1 (de) * 1988-09-16 1990-03-22 Sandoz Ag Cyclosporin enthaltende pharmazeutische formulierungen
DE4003844A1 (de) * 1989-02-09 1990-08-16 Sandoz Ag Neue cyclosporin enthaltende galenische formulierungen
DE4005190A1 (de) * 1989-02-20 1990-08-23 Sandoz Ag Neue cyclosporinhaltige galenische formen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Seifen-Öle-Fette-Wachse 102, 1976, S. 467-469 *

Also Published As

Publication number Publication date
AU659460B2 (en) 1995-05-18
CY1906A (en) 1992-06-24
CA2175842C (en) 2002-05-07
FR2685706B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-12-23
UY23864A1 (es) 1995-05-29
JP3420897B2 (ja) 2003-06-30
CA2175842A1 (en) 1992-12-28
FR2678169A1 (fr) 1992-12-31
JPH09118894A (ja) 1997-05-06
NO922506L (no) 1992-12-28
GB2257359B (en) 1996-01-10
NO964382D0 (no) 1996-10-15
NO325267B1 (no) 2008-03-17
DE4244930C2 (de) 1999-11-11
KR100231384B1 (en) 1999-11-15
HUT62201A (en) 1993-04-28
HU9201975D0 (en) 1992-09-28
RO111110B1 (ro) 1996-06-28
NO922506D0 (no) 1992-06-25
FI922958A0 (fi) 1992-06-25
EP0539319B1 (en) 1999-12-08
SK278759B6 (sk) 1998-02-04
FI116199B (fi) 2005-10-14
DE4244986B4 (de) 2008-07-24
HK157696A (en) 1996-08-30
PT953630E (pt) 2004-11-30
CH684163A5 (de) 1994-07-29
EP0953630A1 (en) 1999-11-03
NO964382L (no) 1992-12-28
ES2227921T3 (es) 2005-04-01
GB9213393D0 (en) 1992-08-05
PH30337A (en) 1997-04-02
AU1852792A (en) 1993-03-11
IE73662B1 (en) 1997-06-18
IL118546A0 (en) 1996-10-16
GB2257359A (en) 1993-01-13
NO303964B1 (no) 1998-10-05
RU2143919C1 (ru) 2000-01-10
IL102310A (en) 1997-03-18
ES2142818T3 (es) 2000-05-01
FR2685706A1 (fr) 1993-07-02
MY109512A (en) 1997-02-28
UA35559C2 (uk) 2001-04-16
MX9203236A (es) 1992-12-01
SA92130213B1 (ar) 2004-07-24
RO111021B1 (ro) 1996-06-28
IL102310A0 (en) 1993-01-14
ATA129892A (de) 1997-07-15
DE4219526A1 (de) 1993-03-18
CA2072509A1 (en) 1992-12-28
IT1254401B (it) 1995-09-14
KR0131064B1 (ko) 1998-04-17
EE03108B1 (et) 1998-08-17
CH685764A5 (de) 1995-09-29
GB9113872D0 (en) 1991-08-14
EP0539319A2 (en) 1993-04-28
GR3032366T3 (en) 2000-04-27
LU88138A1 (fr) 1994-03-01
TW267943B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1996-01-11
DK0953630T3 (da) 2004-11-01
JP2653958B2 (ja) 1997-09-17
KR930000113A (ko) 1993-01-15
HU216792B (hu) 1999-08-30
EP0539319A3 (en) 1993-06-09
FI922958L (fi) 1992-12-28
FI109454B (fi) 2002-08-15
JPH05186365A (ja) 1993-07-27
ZA924719B (en) 1993-12-27
PT539319E (pt) 2000-05-31
NZ243309A (en) 1995-02-24
FR2678169B1 (fr) 1994-08-26
IE922082A1 (en) 1992-12-30
ITRM920476A0 (it) 1992-06-23
CA2072509C (en) 1996-07-30
HK57196A (en) 1996-04-12
DK0539319T3 (da) 2000-05-22
ITRM920476A1 (it) 1993-12-23
AT403436B (de) 1998-02-25
KR100231385B1 (en) 1999-11-15
CN1079907A (zh) 1993-12-29
IL118546A (en) 1998-09-24
CZ281790B6 (cs) 1997-01-15
FI961513A0 (fi) 1996-04-03
FI961513L (fi) 1996-04-03
EP0953630B1 (en) 2004-09-08
CN1077798C (zh) 2002-01-16
CZ197792A3 (en) 1993-01-13
SK197792A3 (en) 1994-03-09

Similar Documents

Publication Publication Date Title
DE4219526C2 (de) Pharmazeutisches Mittel
DE4332436B4 (de) Cyclosporin enthaltende pharmazeutische Zusammensetzungen
DE3930928C2 (de) Cyclosporin enthaltende pharmazeutische Formulierungen
DE69816335T2 (de) Cyclosporin-enthaltende mikroemulsion-vorkonzentratzusammensetzung
DE69531389T2 (de) Cyclosporin enthaltende multiple Emulsionen
CH680650A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE60014162T2 (de) Fenofibrathaltige galenische arzneizusammensetzungen und verfahren zu ihrer herstellung
DE69635720T2 (de) Pharmazeutische Zusammensetzungen von Cyclosporine mit einer Polyethoxylierten hydroxy-fettsäure
DE60027717T2 (de) Orale zusammensetzung zur pilzbehandlung die itraconazol enthält und herstellungsverfahren davon
DE69525019T2 (de) Cyclosporin enthaltende Weichkapselzusammensetzungen
DE3500103C2 (de) Pharmazeutische Zubereitung mit einem in Wasser und Verdauungssäften schwer löslichen Wirkstoff
DE4003844B4 (de) Neue Cyclosporin enthaltende galenische Formulierungen
DE69920668T2 (de) Cyclosporin oder macrolide enthaltende emulsionsvorkonzentrate
DE60019100T2 (de) Im wesentlichen ölfreie cyclosporin zusammensetzungen
DD142149A5 (de) Verfahren zur herstellung resorbierbarer galenischer kompositionen
DE69332078T2 (de) Arzneimittel enthaltende cyclosporinderivate
DE69425859T2 (de) Cyclosporin enthaltende Weichkapsel
DE3610531C2 (de) Arzneimittel mit einem Gehalt an N-(4-Hydroxyphenyl)-retinamid mit erhöhter Bioverfügbarkeit
DE69619700T2 (de) Cyclosporin enthaltende, biologisch aktive zubereitung
DE69511539T2 (de) Eine cyclosporin enthaltende zubereitung und ein verfahren für ihre herstellung
DE69711267T2 (de) Cyclosporin enthaltende Weichkapselpräparate
EP0859626B1 (de) Cyclosprorin(e) enthaltende pharmazeutische zubereitung zur oralen applikation und verfahren zu ihrer herstellung
DE69921409T2 (de) Cyclosporin enthaltende Zusammensetzungen
DE69738656T2 (de) Cyclosporin enthaltende Präparate
DE60018715T2 (de) Pharmazeutische Zusammensetzung enthaltend Cyclosprin als aktiven Bestandteil

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8125 Change of the main classification

Ipc: A61K 38/13

8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 4244930

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 4244930

8127 New person/name/address of the applicant

Owner name: NOVARTIS AG, BASEL, CH

AH Division in

Ref country code: DE

Ref document number: 4244930

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
AH Division in

Ref country code: DE

Ref document number: 4244930

Format of ref document f/p: P

8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

R071 Expiry of right
R071 Expiry of right